Hepatic impairment (mild and moderate, child-pugh class A and B)

Clinical trials for Hepatic impairment (mild and moderate, child-pugh class A and B) explained in plain language.

Never miss a new study

Get alerted when new Hepatic impairment (mild and moderate, child-pugh class A and B) trials appear

Sign up with your email to follow new studies for Hepatic impairment (mild and moderate, child-pugh class A and B), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New liver safety study for experimental drug MDR-001 begins

Knowledge-focused Not yet recruiting

This early-stage study will give a single dose of MDR-001, a GLP-1 receptor agonist tablet, to 32 people: some with mild or moderate liver impairment and some with healthy livers. Researchers want to see how the drug moves through the body and if it is safe in people with liver i…

Matched conditions: HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B)

Phase 1 • Sponsor: MindRank AI Ltd • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:23 UTC

Hepatic impairment (mild and moderate, child-pugh class A and B)

Get alerted when new Hepatic impairment (mild and moderate, child-pugh class A and B) trials appear

New liver safety study for experimental drug MDR-001 begins